News

Eli Lilly in Immunology Pact with Sitryx

Trump’s Promotion of COVID Cure is Media Fodder

AGC Expands Spanish Facilities

Air Liquide Talks with EQT about Schülke Sale

FDA Says Pandemic Hasn’t Hit China’s Drug Exports

UOP Wins Hydrogen Projects in China

GSK Teams again with Innovax on COVID Vaccine

Lanxess Suspends Share Buyback Scheme

Nouryon to Take Sasol’s TEAL Business

Takeda and Evox Link on Rare Diseases

CEFIC Encouraged by REACH Data Action Plan

ISPE Appoints Jean-François Duliere as European Regulatory Advisor

Chemours Lawsuit against DuPont Dismissed

Arkema Outlines Strategy, Proposes Divestments

GPCA Urges Supply Chain Cooperation in Crisis

ChemPubSoc Europe becomes Chemistry Europe

Nouryon Expands Peroxides Partnership with Sumitomo

Azelis Boosts China Presence with CosBond Buy

Azelis is strengthening its position in China with an agreement to buy CosBond, a specialty chemicals and food ingredients distributor headquartered in Hong Kong. The acquisition is expected to close within the next three months. Financial terms were not disclosed.

Bayer Settles Roundup Labeling Class Action

Oqema has Entered into an Agency and Distribution Partnership with Chemada

India Passes Pharma Investment Package

Air Products to Acquire Five Hydrogen Plants

LyondellBasell to Delay Work on PO/TBA Plant

Duke Starts Novel Decontamination of N95 Masks to Help Relieve Shortages

Bayer Collaborates with Curadev

Gilead Rescinds Orphan Drug Request

Advanced and SK Gas Plan PDH/PP Complex

Rystad Predicts Global E&P Capex to Reach at least a 13-Year Low in 2020

Fluor Adopts Poison Pill Strategy

EPA Suspends Enforcement of Pollution Rules

Sanofi and Translate Bio Link on COVID Vaccines

Axens Wins Croatian Bioethanol Project

AstraZeneca Links with Silence Therapeutics

Secarna and Lipigon Sign R&D Pact

HCS Group to Sell Oxo Business to Aeicon